Aurobindo Pharma


'Aurobindo Pharma' - 15 Video Result(s)

'Aurobindo Pharma' - 270 News Result(s)

  • Cabinet To Decide On Axis Bank Rs 12,973 Crore Foreign Investment Proposal

    Cabinet To Decide On Axis Bank Rs 12,973 Crore Foreign Investment Proposal

    The Cabinet Committee on Economic Affairs will take a final call on Axis Bank's Rs 12,973-crore foreign investment proposal, the Finance Ministry said on Wednesday.

  • Aurobindo Gets USFDA Nod For Opioid Analgesic Tablets

    Aurobindo Gets USFDA Nod For Opioid Analgesic Tablets

    Aurobindo Pharma has received final approval from the US health regulator to manufacture and market opioid analgesic Hydromorphone Hydrochloride tablets in the American market.

  • Aurobindo Pharma Gets USFDA Nod For Anaesthetic Injection

    Aurobindo Pharma Gets USFDA Nod For Anaesthetic Injection

    Aurobindo Pharma has received final nod from the US health regulator to manufacture and market its anaesthetic Bupivacaine Hydrochloride injection in the American market.

  • Aurobindo Pharma Gets USFDA Nod For Generic Migraine Drug

    Aurobindo Pharma Gets USFDA Nod For Generic Migraine Drug

    Aurobindo Pharma has received approval from the US health regulator to sell generic Zolmitriptan tablets, a drug used to treat migraine, in the American market.

  • Aurobindo Pharma Gets Final USFDA Nod For Cholesterol Drug

    Aurobindo Pharma Gets Final USFDA Nod For Cholesterol Drug

    According to IMS, the approved product has an estimated market size of $412 million for the twelve months ended March 2016, Aurobindo Pharma said.

  • Nifty Unlikely To Fall Below 7,500, Buy TVS Motor: Shahina Mukadam

    Nifty Unlikely To Fall Below 7,500, Buy TVS Motor: Shahina Mukadam

    Domestic equities have been pressured by events in the international markets, making bulls a bit nervous, says market expert Shahina Mukadam. Stocks like Reliance Industries, ICICI Bank and other banking shares as a whole are contributing to the fall and keeping markets subdued, she added.

  • Aurobindo Gets US Nod For Seizures Treatment Drug

    Aurobindo Gets US Nod For Seizures Treatment Drug

    Aurobindo Pharma has received final approval from the US health regulator for its Lacosamide tablets used for treatment of partial-onset seizures in American market.

  • Aurobindo Pharma Gets USFDA Nod For Two Drugs

    Aurobindo Pharma Gets USFDA Nod For Two Drugs

    Aurobindo Pharma on Wednesday said it has received final approval from the US health regulator to manufacture and market generic version of heartburn relief medicine Famotidine tablets.

  • Aurobindo Pharma Gets USFDA Nod For Blood Pressure Drug

    Aurobindo Pharma Gets USFDA Nod For Blood Pressure Drug

    Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market generic version of blood pressure treatment drugs Amlodipine and Valsartan tablets.

  • Aurobindo Pharma Gets US Regulator's Nod for Gastro Reflux Drug

    Aurobindo Pharma Gets US Regulator's Nod for Gastro Reflux Drug

    Drug firm Aurobindo Pharma has received final approval from US Food and Drug Administration (FDA) to manufacture and market Esomeprazole Magnesium delayed release capsules, used in treatment of gastro-esophageal reflux disease, in the American market.

  • Finance Ministry Looks To Expedite Clearances To FDI Proposals

    Finance Ministry Looks To Expedite Clearances To FDI Proposals

    Stressing that fast clearances and automatic process are key to recent surge in FDI inflows, Economic Affairs Secretary Shaktikanta Das on Thursday said all FDI applications received up to March 15 are listed in agenda for the next meeting of Foreign Investment Promotion Board (FIPB).

  • Investment Board To Take Up Axis Bank, 13 Other Proposals

    Investment Board To Take Up Axis Bank, 13 Other Proposals

    FIPB, chaired by Economic Affairs Secretary Shaktikanta Das, will also consider the proposal of Aurobindo Pharma, One97 Communications, Advanced Enzyme Technologies and Macmillan Publishers International Ltd.

  • Aurobindo Gets US Nod For Generic Anti-Infective Drug

    Aurobindo Gets US Nod For Generic Anti-Infective Drug

    Drug firm Aurobindo Pharma has received approval from the US health regulator to market Polymyxin B for Injection, an anti-infective drug, in the American market.

  • Aurobindo Gets USFDA Nod For Generic Anti-Infective Drug

    Aurobindo Gets USFDA Nod For Generic Anti-Infective Drug

    The approved product has an estimated market size of $7.6 million for the twelve months ending February 2016, according to IMS, the company said.

  • Aurobindo Pharma Gets Final USFDA Nod For Anti-viral Drug

    Aurobindo Pharma Gets Final USFDA Nod For Anti-viral Drug

    Aurobindo Pharma has received final approval from the US health regulator to manufacture and market anti-viral Valganciclovir tablets in the American market.

................................ Advertisement ................................

................................ Advertisement ................................